UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Prior Warrants and Pre-funded Warrants	At-the-Market Offering	PREFERRED STOCK	COMMON STOCK	COMMON STOCK At-the-Market Offering	ADDITIONAL PAID-IN CAPITAL	ADDITIONAL PAID-IN CAPITAL At-the-Market Offering	ACCUMULATED DEFICIT	ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
Beginning balance (in shares) at Dec. 31, 2023				15,000
Beginning balance at Dec. 31, 2023				$ 0
Beginning balance (in shares) at Dec. 31, 2023					29,130,607
Beginning balance at Dec. 31, 2023	$ 21,291				$ 3		$ 418,487		$ (397,198)	$ (1)
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,731)								(1,731)
Unrealized Gain on Available-for-Sale Investments	25									25
Issuance of common stock, net of offering costs/At-The-Market (in shares)						358,210
Issuance of Common Stock, net of offering costs/At-the-Market Offering			$ 560					$ 560
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)					67,657
Adjustments to Additional Paid in Capital, Warrant Issued	247						247
Stock-based Compensation	251						251
Ending balance (in shares) at Mar. 31, 2024				15,000
Ending balance at Mar. 31, 2024				$ 0
Ending balance (in shares) at Mar. 31, 2024					29,556,474
Ending balance at Mar. 31, 2024	20,643				$ 3		419,545		(398,929)	24
Beginning balance (in shares) at Dec. 31, 2023				15,000
Beginning balance at Dec. 31, 2023				$ 0
Beginning balance (in shares) at Dec. 31, 2023					29,130,607
Beginning balance at Dec. 31, 2023	21,291				$ 3		418,487		(397,198)	(1)
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	276
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(25)
Foreign Currency Translation Adjustments	$ (4)
Ending balance (in shares) at Sep. 30, 2024				15,000
Ending balance at Sep. 30, 2024				$ 0
Ending balance (in shares) at Sep. 30, 2024	32,318,806				32,318,806
Ending balance at Sep. 30, 2024	$ 29,135				$ 3		426,046		(396,922)	8
Beginning balance (in shares) at Mar. 31, 2024				15,000
Beginning balance at Mar. 31, 2024				$ 0
Beginning balance (in shares) at Mar. 31, 2024					29,556,474
Beginning balance at Mar. 31, 2024	20,643				$ 3		419,545		(398,929)	24
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	343								343
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(25)									(25)
Foreign Currency Translation Adjustments	(4)									(4)
Issuance of common stock, net of offering costs/At-The-Market (in shares)						1,350,169
Issuance of Common Stock, net of offering costs/At-the-Market Offering			2,203					2,203
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)					123,575
Stock-based Compensation	338						338
Ending balance (in shares) at Jun. 30, 2024				15,000
Ending balance at Jun. 30, 2024				$ 0
Ending balance (in shares) at Jun. 30, 2024					31,030,218
Ending balance at Jun. 30, 2024	23,498				$ 3		422,086		(398,586)	(5)
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	1,664								1,664
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	0
Foreign Currency Translation Adjustments	0
Unrealized Gain on Available-for-Sale Investments	13									13
Issuance of common stock, net of offering costs/At-The-Market (in shares)						1,282,546
Issuance of Common Stock, net of offering costs/At-the-Market Offering			3,630					3,630
Issuance of Common Stock upon Exercise of Options (in shares)					6,042
Issuance of Common Stock upon Exercise of Options		$ 9					9
Stock-based Compensation	$ 321						321
Ending balance (in shares) at Sep. 30, 2024				15,000
Ending balance at Sep. 30, 2024				$ 0
Ending balance (in shares) at Sep. 30, 2024	32,318,806				32,318,806
Ending balance at Sep. 30, 2024	$ 29,135				$ 3		426,046		(396,922)	8
Beginning balance (in shares) at Dec. 31, 2024	15,000			15,000
Beginning balance at Dec. 31, 2024	$ 0			$ 0
Beginning balance (in shares) at Dec. 31, 2024	34,056,920				34,056,920
Beginning balance at Dec. 31, 2024	$ 32,586				$ 3		430,207		(397,678)	54
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,515)								(1,515)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(56)									(56)
Unrealized Gain on Available-for-Sale Investments	62									62
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)					200,983
Stock-based Compensation	445						445
Ending balance (in shares) at Mar. 31, 2025				15,000
Ending balance at Mar. 31, 2025				$ 0
Ending balance (in shares) at Mar. 31, 2025					34,257,903
Ending balance at Mar. 31, 2025	$ 31,522				$ 3		430,652		(399,193)	60
Beginning balance (in shares) at Dec. 31, 2024	15,000			15,000
Beginning balance at Dec. 31, 2024	$ 0			$ 0
Beginning balance (in shares) at Dec. 31, 2024	34,056,920				34,056,920
Beginning balance at Dec. 31, 2024	$ 32,586				$ 3		430,207		(397,678)	54
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(4,760)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(181)
Foreign Currency Translation Adjustments	$ 0
Ending balance (in shares) at Sep. 30, 2025	15,000			15,000
Ending balance at Sep. 30, 2025	$ 0			$ 0
Ending balance (in shares) at Sep. 30, 2025	39,405,301				39,405,301
Ending balance at Sep. 30, 2025	$ 37,020				$ 4		439,381		(402,438)	73
Beginning balance (in shares) at Mar. 31, 2025				15,000
Beginning balance at Mar. 31, 2025				$ 0
Beginning balance (in shares) at Mar. 31, 2025					34,257,903
Beginning balance at Mar. 31, 2025	31,522				$ 3		430,652		(399,193)	60
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,492)								(1,492)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(64)									(64)
Unrealized Gain on Available-for-Sale Investments	61									61
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)					172,449
Stock-based Compensation	382						382
Ending balance (in shares) at Jun. 30, 2025				15,000
Ending balance at Jun. 30, 2025				$ 0
Ending balance (in shares) at Jun. 30, 2025					34,430,352
Ending balance at Jun. 30, 2025	30,409				$ 3		431,034		(400,685)	57
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,753)								(1,753)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(61)									(61)
Foreign Currency Translation Adjustments	0
Unrealized Gain on Available-for-Sale Investments	77									77
Issuance of common stock, net of offering costs/At-The-Market (in shares)						4,964,636
Issuance of Common Stock, net of offering costs/At-the-Market Offering			$ 7,800			$ 1		$ 7,799
Issuance of Common Stock upon Exercise of Options (in shares)					10,313
Issuance of Common Stock upon Exercise of Options		$ 16					16
Stock-based Compensation	$ 532						532
Ending balance (in shares) at Sep. 30, 2025	15,000			15,000
Ending balance at Sep. 30, 2025	$ 0			$ 0
Ending balance (in shares) at Sep. 30, 2025	39,405,301				39,405,301
Ending balance at Sep. 30, 2025	$ 37,020				$ 4		$ 439,381		$ (402,438)	$ 73